Generic Name and Formulations:
Hydrogen peroxide 40% w/w; topical soln.
Indications for ESKATA:
Raised seborrheic keratoses.
For topical application by healthcare provider. Apply 4 times to targeted lesion(s) approx. 1min apart during a single session. May administer another treatment if lesions have not cleared after 3 weeks.
Not for oral, ophthalmic, or intravaginal use. Avoid open or infected seborrheic keratoses, lesions within orbital rim, eyes and mucous membranes.
Erythema, stinging, edema, scaling, crusting, pruritus, vesiculation, erosion, ulceration, hyper/hypopigmentation.
Pen applicator (1.5mL, 2.2mL)—1, 3, 12
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Link Identified Between Cured Meat and Mania in Bipolar Disorder
- Early Risk Factors for Bipolar Disorder Found in Offspring of BD Parents
- First-Episode Delusional Disorder vs Schizophrenia: Assessment of Outcomes
- Daily Drinking Associated With Increased Mortality Risk
- Probiotics, Depression, and the Role of Inflammation
- The Opioid System: The Foundation for Social Risk and Reward
- Correctional Psychiatry: Challenges and Rewards
- Those Left Behind: Working With Suicide-Bereaved Families
- Is Mandatory Reporting of Child Maltreatment in the Best Interests of the Child?
- The Impact of Deafness on Hallucinations and Delusions
- High Risk for Anxiety, Depression, and Stress Observed Among Single Mothers
- Self-Harm, Suicidality Among Adolescents Associated With Poor Outcomes, Recurrent Clinical Care
- Moderate Association Between Sociocognitive Functioning and Thought Disorder in Schizophrenia
- Psychotropic Medications May Improve Pregnancy Outcomes in Bipolar Disorder
- Schizophrenia Polygenetic Risk Score as a Predictor of Bipolar Disorder With Psychosis